Potassium Chloride Capsule, Extended Release
Product Images NDC 62037-559

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 62037-559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Potassium Chloride Extended-release Capsules Usp (600 mg) 8 Meq K, 100 Capsules Container Label (Image 1)

This is a description of a medication with the NDC number 62037-559-01. It is an extended-release potassium chloride capsule containing 8 milliequivalents of microencapsulated KCl, intended for release over a 1 hour period. This medication is only available by prescription and should be stored at a temperature between 20-25°C as defined by the USP. The usual dosage instructions can be found in the accompanying package insert. This medication is manufactured by Ao Labastones, located in Florida, and distributed by Actavis Pharma in New Jersey.*

FDA Label Image

1 (Image 2)

Potassium Chloride Extended-Release Capsules, USP containing 90 capsules of 10 mg each and manufactured by Actavis. These capsules contain microencapsulated KC1 which is designed to release the active ingredient over a 8-10 hour period. It is recommended to store these capsules in a tight container between 20-25°C. The usual dosage is mentioned in the accompanying package insert. The product is for Rx only and needs to be dispensed in a tight container as specified in the USP. It is distributed by Actavis Pharma.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.